Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen to Manufacture RNA Control Kits for Affy-Based Tests


By Justin Petrone

Asuragen said last week that it will develop and manufacture RNA control kits for Affymetrix.

The control kits are intended for use with Asuragen-made in vitro transcription reagent kits for clinical molecular diagnostic applications that run on the Affy platform.

Austin, Tex.-based Asuragen said the kits will be configured for use with the GeneChip System 3000Dx version 2, and will be made available to companies developing and commercializing tests on the GeneChip platform. There are currently more than 20 different molecular assay tests based on the Affy platform under development by Affy and 11 partners, Asuragen said.

Asuragen inked a deal to manufacture in vitro transcription reagent kits for use with Affy's diagnostic microarray platform in July 2008 (see BAN 7/8/2008). The companies have also cooperated on other products. Asuragen began offering DiscovArray, an Affy-manufactured chip for microRNA expression profiling, in 2007 (see BAN 8/7/2007).

Financial details of the new agreement were not discussed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.